Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2014 (2014), Article ID 819216, 5 pages
Research Article

What Do Healthcare Providers Advise Women with Multiple Sclerosis Regarding Pregnancy?

1Department of Neurology, Multiple Sclerosis Center, University of Washington, McMurry Building, 1536 N. 115th Street, Seattle, WA 98113, USA
2Department of Rehabilitation Medicine, University of Washington, Box 359612, Seattle, WA 98195, USA

Received 30 October 2013; Revised 14 January 2014; Accepted 1 February 2014; Published 5 March 2014

Academic Editor: Antonio Bertolotto

Copyright © 2014 Annette Wundes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Pregnancy in multiple sclerosis (MS) is considered safe for both the woman and the child. Nevertheless, pregnancy issues in MS are complex both from a patient’s and a provider’s perspective. In an anonymous survey, 28 healthcare providers in the United States reported on the management of multiple sclerosis (MS) during pregnancy. Participants were asked about their recommendations to patients about the use of disease modifying therapies during pregnancy and breastfeeding and general recommendations about MS and pregnancy. Healthcare providers were also asked about sources from which they receive information about the management of patients with MS. Results suggested that healthcare providers do not discourage pregnancy for women with MS, recommend that women not use disease modifying therapies while pregnant, and have a positive view of breastfeeding for women with MS. Results also indicated the need for guidelines on patient management for pregnant women with MS.